LncRNA Rmst-driven DNMT3A mRNA stabilization through HuR: implications for neuropathic pain therapy

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Neuropathic pain (NP) is a debilitating condition with complex underlying mechanisms.
• DNA methyltransferase 3A (DNMT3A) plays a role in epigenetic regulation relevant to pain.
• Long non-coding RNAs (lncRNAs) are emerging as key regulators in various biological processes, including neurological disorders.

Purpose of the Study:

• To investigate the role of lncRNA Rmst in regulating DNMT3A expression.
• To determine the impact of the Rmst-DNMT3A interaction on neuropathic pain development and progression.

Main Methods:

• Utilized a SAM-based lncRNA library screening system to identify regulatory lncRNAs.
• Established spared nerve injury (SNL) and chronic constriction injury (CCI) rat models for neuropathic pain.
• Employed knockdown of Rmst and overexpression of DNMT3A in vivo using microinjection and lentiviral vectors.
• Conducted qRT-PCR, Western blot, in situ hybridization, immunofluorescence, dual-luciferase reporter assays, and RNA immunoprecipitation (RIP).
• Assessed pain-related behaviors and measured inflammatory markers and neuronal excitability.

Main Results:

• Identified Rmst as a significantly upregulated lncRNA in neuropathic pain models.
• Knockdown of Rmst reduced DNMT3A expression, neuronal excitability, microglial activation, and inflammatory factors in rat models.
• Demonstrated that Rmst interacts with HuR to stabilize DNMT3A mRNA.
• Showed that DNMT3A overexpression exacerbates pain sensitivity, inflammation, and microglial activation in mice.

Conclusions:

• LncRNA Rmst stabilizes DNMT3A mRNA through interaction with HuR, contributing to neuropathic pain progression.
• The Rmst-HuR-DNMT3A axis represents a critical pathway in neuropathic pain.
• Targeting this axis presents a promising therapeutic avenue for managing neuropathic pain.